Renovatio Clinical

Houston, Texas 77380

1 studies enrolling now · 10 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency, Alpha1-Antitrypsin Deficiency, Follicular Lymphoma (FL), HCC, Hepatocellular Carcinoma, Lymphoma, Marginal Zone Lymphoma, Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Myelofibrosis, Non Hodgkin Lymphoma

Studies at this site

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype — Stopped early
• A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain — Completed
• Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas — Stopped early
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma — Status unconfirmed
• Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype — Completed
• Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype — Stopped early
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling